Medicare & Medicaid

A regional inspector general for the U.S. Department of Health and Human Services explains oversight of a multi-billion-dollar trend in Medicare spending.

A regional inspector general for the U.S. Department of Health and Human Services explains oversight of a multi-billion-dollar trend in Medicare spending.

A regional inspector general for the U.S. Department of Health and Human Services explains oversight of a multi-billion-dollar trend in Medicare spending.

A regional inspector general for the U.S. Department of Health and Human Services explains oversight of a multi-billion-dollar trend in Medicare spending.

Ohio State researchers say the billionaire entrepreneur’s Cost Plus Drug Company exposes how insurance premiums and middlemen drive up the true cost of neurologic medications.

A regional inspector general for the U.S. Department of Health and Human Services explains oversight of a multi-billion-dollar trend in Medicare spending.

A regional inspector general for the U.S. Department of Health and Human Services explains oversight of a multi-billion-dollar trend in Medicare spending.

Feds highlight huge growth in spending on wound care and why it could be problematic in health care.

At the MGMA Leaders Conference 2025 in Orlando, speakers broke down the Trump administration's effect on health policy.

Out-of-pocket costs for popular diabetes and weight-related medications nearly doubled in 2025, with nearly universal prior authorization requirements, according to new JAMA research.

From Rhode Island to California, states are experimenting with ways to funnel more money into primary care, though it’s uncertain whether those investments can rein in overall health costs.

Medicaid cuts threaten essential care for special needs children, risking their health and increasing costs. There is a better solution.

A JAMA viewpoint argues new reimbursement policies may deliver long-sought revenue to primary care, though uptake, staffing and fee cuts elsewhere cloud the outlook.

CMS announces application details as RFK calls it ‘the largest investment ever made’ to improve rural health.

MGMA, Accountable for Health offer analyses of 2026 Medicare Physician Fee Schedule.

Comments published about next year’s Medicare Physician Fee Schedule.

Leaders of the Milbank Memorial Fund, Robert Graham Canter and Primary Care Collaborative discuss a key part of the U.S. health care system.

Accountable care organizations boosted Medicare’s bottom line and improved patient outcomes in 2024, with physician-led groups reporting the strongest results.

New analysis argues that Medicare’s payment system undervalues cognitive effort in primary care, contributing to physician shortages and reduced patient access.

Anders Gilberg, SVP of government affairs at MGMA, joins the show with health policy updates from Washington.

Patients in value-based care practices were nearly 28% more likely to receive full guideline-directed therapy.

67 health organizations sign letter urging faster access and coverage

More developments and data around the finances and patient outcomes of traditional Medicare and Medicare Advantage.

Analyst J.D. Power releases 2025 Medicare Advantage report.

Potential changes for remote physiologic monitoring and remote therapeutic monitoring in the 2026 Medicare Physician Fee Schedule.